Vulvar Melanoma in association with germline MITF p.E318K variant

BK, 2004, Primary malignant melanoma of the vulva–an aggressive tumor for modeling the genesis of non-UV light-associated melanomas, Acta Oncol, 43, 421, 10.1080/02841860410031372 Campaner, 2017, Vulvar melanoma: relevant aspects in therapeutic management, An Bras Dermatol, 92, 398, 10.1590/abd1806-4841.20174941 Heinzelmann-Schwarz, 2014, A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker, Int J Mol Med, 33, 784, 10.3892/ijmm.2014.1659 Baloglu, 2009, Primary malignant melanoma of the vagina, Arch Gynecol Obstet, 280, 819, 10.1007/s00404-009-1009-0 Wang, 2020, Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management, Am J Cancer Res, 10, 4017 Kalampokas, 2017, Primary vaginal melanoma, a rare and aggressive entity. A case report and review of the literature, In Vivo., 31, 133, 10.21873/invivo.11036 Jamaer, 2020, Primary malignant melanoma of the vagina, BMJ Case Rep, 13, 10.1136/bcr-2019-232200 Zhou, 2019, Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations, Clin Cancer Res, 25, 3548, 10.1158/1078-0432.CCR-18-3442 Newell, 2019, Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets, Nat Commun, 10, 3163, 10.1038/s41467-019-11107-x Hu, 2010, Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas, Melanoma Res, 20, 153, 10.1097/CMR.0b013e32833684e8 Hou, 2017, Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma, Cancer, 123, 1333, 10.1002/cncr.30473 De Simone, 2008, Vulvar melanoma: a report of 10 cases and review of the literature, Melanoma Res, 18, 127, 10.1097/CMR.0b013e3282f94636 Omholt, 2011, KIT pathway alterations in mucosal melanomas of the vulva and other sites, Clin Cancer Res, 17, 3933, 10.1158/1078-0432.CCR-10-2917 Wechter, 2004, Vulvar melanoma: a report of 20 cases and review of the literature, J Am Acad Dermatol, 50, 554, 10.1016/j.jaad.2003.07.026 Cronin, 2009, Frequent mutations in the MITF pathway in melanoma, Pigment Cell Melanoma Res, 22, 435, 10.1111/j.1755-148X.2009.00578.x Guhan, 2020, Cancer risks associated with the germline MITF(E318K) variant, Sci Rep, 10, 17051, 10.1038/s41598-020-74237-z Bertolotto, 2011, A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, 480, 94, 10.1038/nature10539 Yokoyama, 2011, A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, 480, 99, 10.1038/nature10630 Ghiorzo, 2013, Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history, Pigment Cell Melanoma Res, 26, 259, 10.1111/pcmr.12047 Bruno, 2016, Multiple primary melanomas (MPMs) and criteria for genetic assessment: multiMEL, a multicenter study of the Italian Melanoma Intergroup, J Am Acad Dermatol, 74, 325, 10.1016/j.jaad.2015.09.053 Berwick, 2014, MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors, Pigment Cell Melanoma Res, 27, 485, 10.1111/pcmr.12215 Potrony, 2016, Prevalence of MITF p.E318K in patients with melanoma independent of the presence of CDKN2A causative mutations, JAMA Dermatol, 152, 405, 10.1001/jamadermatol.2015.4356 Mangas, 2016, Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF, Br J Dermatol, 175, 1030, 10.1111/bjd.14897 Desmond, 2015, Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment, JAMA Oncol, 1, 943, 10.1001/jamaoncol.2015.2690 Kurian, 2014, Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment, J Clin Oncol, 32, 2001, 10.1200/JCO.2013.53.6607 Koeller, 2020, Novel Pathogenic germline variant of the Adenomatous polyposis Coli (APC) Gene, p.S2627Gfs*12 identified in a mild phenotype of APC-Associated polyposis: a case report, Am J Case Rep, 21, 10.12659/AJCR.927293 Potrony, 2015, Update in genetic susceptibility in melanoma, Ann Transl Med, 3, 210 Garraway, 2005, Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, 436, 117, 10.1038/nature03664 1991, Multicenter survey of diabetic pregnancy in France. Gestation and diabetes in france study group, Diabetes Care, 14, 994, 10.2337/diacare.14.11.994 Ciccarese, 2020, Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients, J Transl Med, 18, 78, 10.1186/s12967-020-02253-8